Cardiol Therapeutics Inc. Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
Cardiol Therapeutics Inc. (CRDL) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of 1.48 CAD/shares for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2026-03-31
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.48 CAD/shares 40-F · filed 2026-03-31 | |
| 2024-12-31 | 2.56 CAD/shares 40-F · filed 2026-03-31 | 2.53 CAD/shares 40-F · filed 2025-03-31 |
| 2023-12-31 | 1.58 CAD/shares 40-F · filed 2025-03-31 | |
| 2022-12-31 | 1.84 CAD/shares 20-F · filed 2024-04-01 | |
| 2021-12-31 | 4.04 CAD/shares 20-F · filed 2024-04-01 | |
| 2020-12-31 | 2.73 CAD/shares 20-F · filed 2023-03-29 |